يعرض 1 - 10 نتائج من 66 نتيجة بحث عن '"Niculescu-duvaz, D"', وقت الاستعلام: 1.15s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., Holovanchuk, D., Pedersen, M., Mcleary, R., Lorigan, P., Dhomen, N., Fisher, C., Banerji, U., Dean, E., Krebs, M. G., Gore, M., Larkin, J., Marais, R., Springer, C.

    مصطلحات موضوعية: CRC, KRAS, NSCLC, panRAF/SRC inhibitor, PDAC

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33130216; info:eu-repo/semantics/altIdentifier/wos/WOS:000608030000017; volume:32; issue:2; firstpage:269; lastpage:278; numberofpages:10; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11380/1215608Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098875008

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: http://usir.salford.ac.uk/id/eprint/42157/1/ncomms14909.pdfTest; Tang, H, Leung, L, Saturno, G, Viros, A, Smith, D, Di Leva, G orcid:0000-0002-7656-510X , Morrison, E, Niculescu-duvaz, D, Lopes, F, Johnson, L, Dhomen, N, Springer, C and Marais, R 2017, 'Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface' , Nature Communications, 8 , p. 14909.

  5. 5
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://openaccess.sgul.ac.uk/id/eprint/108803/1/1-s2.0-S1535610817300508-main.pdfTest; Girotti, MR; Lopes, F; Preece, N; Niculescu-Duvaz, D; Zambon, A; Davies, L; Whittaker, S; Saturno, G; Viros, A; Pedersen, M; et al. Girotti, MR; Lopes, F; Preece, N; Niculescu-Duvaz, D; Zambon, A; Davies, L; Whittaker, S; Saturno, G; Viros, A; Pedersen, M; Suijkerbuijk, BMJM; Menard, D; McLeary, R; Johnson, L; Fish, L; Ejiama, S; Sanchez-Laorden, B; Hohloch, J; Carragher, N; Macleod, K; Ashton, G; Marusiak, AA; Fusi, A; Brognard, J; Frame, M; Lorigan, P; Marais, R; Springer, C (2017) Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma. Cancer Cell, 31 (3). p. 466. ISSN 1878-3686 https://doi.org/10.1016/j.ccell.2017.02.007Test SGUL Authors: Fusi, Alberto

  6. 6
    دورية أكاديمية

    المصدر: Dean , E , Banerji , U , Girotti , R , Niculescu-Duvaz , I , Lopes , F , Davies , L , Niculescu-Duvaz , D , Dhomen , N , Ellis , S , Ali , Z , O'Carrigan , B , Carter , L , Chisolm , L , Dive , C , Lane , HA , Lorigan , P , Gore , ME , Larkin , J , Marais , R & Springer , C 2016 , A Phase 1 first-in-human trial to evaluate the safety and tolerability of CCT3833, an oral panRAF inhibitor, in ....

  7. 7
    دورية أكاديمية

    المساهمون: Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK

    العلاقة: https://dx.doi.org/10.1038/s41467-019-11220-xTest; Tang H, Leung L, Saturno G, Viros A, Smith D, Leva GD, et al. Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface. Nat Commun. 2019 Jul 18;10(1):3151.; http://hdl.handle.net/10541/621988Test; Nature Communications

  8. 8
    دورية أكاديمية

    المساهمون: Girotti, M. R., Lopes, F., Preece, N., Niculescu-Duvaz, D., Zambon, A., Davies, L., Whittaker, S., Saturno, G., Viros, A., Pedersen, M., Suijkerbuijk, B. M. J. M., Menard, D., Mcleary, R., Johnson, L., Fish, L., Ejiama, S., Sanchez-Laorden, B., Hohloch, J., Carragher, N., Macleod, K., Ashton, G., Marusiak, A. A., Fusi, A., Brognard, J., Frame, M., Lorigan, P., Marais, R., Springer, C.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28292443; info:eu-repo/semantics/altIdentifier/wos/WOS:000396276700017; volume:31; issue:3; firstpage:N/A; lastpage:N/A; journal:CANCER CELL; http://hdl.handle.net/11380/1287232Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85015077534

  9. 9
    دورية أكاديمية
  10. 10